Parallel Industries

Parallel Industries EPS Growth

The EPS Growth of Parallel Industries (EAPH) as of Nov 19, 2026 is 41.66 %. In the previous year, EPS Growth was -90.97 % — a change of -145.79% (higher).

EPS Growth

41.66 %

YoY

-145.79%

Last updated:

EPS Growth of Parallel Industries is 2020 41.66 % . EPS Growth of Parallel Industries was 2019 -90.97 % . It decreases by -145.79% higher compared to the previous year.

The Parallel Industries EPS Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS Growth
Date
EPS Growth
Jan 1, 2015
-66.26 USD
Jan 1, 2016
-45.48 USD
Jan 1, 2017
71.90 USD
Jan 1, 2018
95.53 USD
Jan 1, 2019
-90.97 USD
Jan 1, 2020
41.66 USD
The Parallel Industries EPS Growth history
YEAREPS GrowthYoY
41.66 %-145.79%
-90.97 %-195.22%
95.53 %+32.87%
71.90 %-258.07%
-45.48 %-31.35%
-66.26 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parallel Industries Stock analysis

What does Parallel Industries do? Easton Pharmaceuticals Inc. is a Canada-based company specializing in the healthcare sector and alternative medicines. It was founded in 1997 and has been listed on the Canadian Securities Exchange since 2014. The company distributes its products in the United States, Canada, Mexico, Europe, and Asia, offering a wide range of products and services including medications, medical devices, cosmetics, supplements, and agricultural products. It operates in various sectors such as the pharmaceutical industry, cosmetics industry, agricultural industry, and medical devices industry. The main business areas of the company are pharmaceuticals and cosmetic products, offering medications for neuropathic pain, chronic fatigue pain, arthritis, as well as cosmetic products with organic ingredients tailored to specific skin needs. Easton Pharmaceuticals also has a presence in the agricultural market, providing fertilizers and pesticides to promote plant growth and increase crop yields. Additionally, the company offers medical devices such as wound dressings, splints, and bandages for injury treatment. It has also invested in real estate for the development of large shopping centers and hotels. The company's business model focuses on providing products and services specifically tailored to the needs of individuals preferring alternative medicines and beauty products. Easton Pharmaceuticals continually strives to expand its brands and introduce new products to the market, while collaborating with other companies to find innovative solutions to medical and health-related problems. In 2020, Easton Pharmaceuticals entered the cannabis sector by signing an agreement with a Canadian company for hemp seed production and marketing. Overall, Easton Pharmaceuticals is a multi-sector company aiming to offer products and services tailored to specific individuals' needs, with a reputation in the industry and a commitment to expanding its presence in the future. Parallel Industries is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parallel Industries stock

EPS Growth of Parallel Industries is 41.66 % in 2020.

On Eulerpool you can find the complete historical development of EPS Growth Parallel Industries since 2006 – with annual values, charts, and detailed analysis.

EPS growth measures the percentage change in earnings per share. It accounts for both profit changes and share count changes.

To evaluate EPS Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EPS Growth.

EPS Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EPS Growth's Parallel Industries historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Parallel Industries

All Key Metrics — Parallel Industries